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Statistical Evaluation of Factors
Influencing Prognosis of Gastric Cancer
Patients: Prediction of Prognosis on
Patient Clusters
by Masashi Goto,* Yoshihiro Matsubara,* Hiroaki
Nakazato,t Kimiyuki Kato,t and Chooichiro Asanot
We found ten clusters of gastric cancer patients in bnanaga's group under a cancer research project
organizedbytheMinistryofHealthandWelfare, andevaluatedthepredictionofprognosisofthosepatients
ineachclusterbyusingthecensored regressionofpostsurgicalsurvivaltimeona "prognosic" factorwhich
hasbeenextracted from nineexplanatory variablesobserved mainly atthetime ofsurgery. Consequently,
the ten clusters were interpreted and confirmed to be useful for prediction of the patient prognosis by
comparisonofthefailure ratesamongthoseclustersandbetweentreated (administration ofchemotherapy)
group and control group.
Introduction
The survival time is one of the leading criteria
necessary for the evaluation of treatments adminis-
tered, to cancer patients. Especially in clinical trials
in cancer therapy, the survival time expressed in
termsofmonths hasbeenused as a measure to assess
the performance ofthe therapy. Variables or factors
which affect or explain the survival time are called
prognostic variables or prognostic factors, respec-
tively. In an ideal clinical trial, it is desirable that
prognostic factors be selected prior to random as-
signment ofeach treatment to be compared and then
evaluation of the results be given by the aid of
observed survival time expressed in months, but
prognostic factors conceivable beforehand are so
numerous that it is difficult to specify the factors in
advance. It is merely in the last decade that the
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prognostic variables have achieved recognition of
theirusefulnesseitherincomparison orinevaluation
of treatments administered in the clinical trial.
Imanaga's group under a cancer research project
organized by the Ministry ofHealth and Welfare has
carried out a survey as a part of the project for
evaluating cancer chemotherapy on patients with
stomach cancer (1). The cases are documented in
four studies; the first one starting on January 1965,
the second on June 1966, the third study starting on
March 1969, and the fourth on January 1971. The
survey is still in progress. Under these circum-
stances, some attempts have been made since 1964,
utilizing the data obtained, to determine prognostic
factors ofchemotherapy on stomach cancerpatients
having undergone surgery. Focusing our attention
on those in the first study with their records oflong
follow-up period, the data have been analyzed in
order to examine three subjects.
Thefirst is to predictpostsurgical prognosis ofthe
patients who suffered from gastric cancer based on
those factors which can be clarified at the time of
surgery. Generally, survival time relates survival
time to the prognostic factors on a previously as-
sumed model and then extracts the individual
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gical survival time and the prognostic factors.
Therefore two problems may arise from evaluation
of the model: the evaluation of the possibility of
prediction of prognosis and the prediction of prog-
nosis. Careful discrimination ofthetwoisimportant.
The second subject of study is to clarify the ap-
propriateness of the time period, usually taken as
about five years after surgery, that has been empiri-
cally said to be the time point which divides a
"good" prognosis from a "bad" prognosis. The
evaluation ofprognosis should be made also in con-
nection with prognostic factors.
The third study subject is an evaluation of the
effect of adjuvant chemotherapy, the primary pur-
poseoftheproject, inconnectionwiththeprognostic
factors.
The analytic methods for these approaches have
also been improved and extended several times in
the course of the analysis.
With respect to the first purpose, based upon the
cases collected through the first survey in the proj-
ect, one prognostic factor was extracted out of nine
factors clarified at the time of surgery and then re-
latedtothepostsurgical survival time inmonths. The
results suggested that critical point to distinguish
those dying shortly aftersurgery fromlong-term sur-
vivors can be placed around 5 years afterthe surgery
(1). With respect to the second purpose, the same
cases as stated above were classified into four
groups, depending on their survival or death at a
point five years after surgery with or without post-
surgical chemotherapy. Comparison ofcharacteris-
tics and canonical analysis among the groups indi-
cated that the discrimination between the dead and
the survivors at five years after surgery could be
assessed with a probability of misclassification of
24.7%. With respect to the third purpose, the rela-
tively large contribution of the presence or absence
of serosal invasion to prognosis in stomach cancer
was proved based on the canonical analysis. Post-
surgical chemotherapy given;ats1 also prolonged the
survival time significantly by about 34 months.
Difficulties in such an analysis ofthe data, first of
all, are that when a number offragmental pieces of
information are taken from a specific patient with an
incurable disease to characterize the survival time of
patients taking them as explanatory variables, there
arise two problems: that ofover-fitting, in which the
numberofexplanatory variables becomes excessive
as compared with the sample size, and that of near
singularity due to the existence of high correlation
between the explanatory variables, which require a
reduction in dimension of the data. In our previous
report (1), the nine factors clarified at surgery was
reduced to one prognostic factor, and survival-time
analysis was carried out based on the prognostic
factors. Next, the existence of censored observa-
tions cause another difficulty, because the censored
observations are not avoidable in an actual study of
the survivorship ofagroup ofpatients. Although the
censored observations did not appreciably affect the
results related to the evaluation of prognosis men-
tioned above, censored adjustment is necessary for
carrying out prediction ofprognosis, especially pre-
diction of postsurgical survival time by the aid of
regression on the prognostic factor.
Though, the resultsgivenintheprevious report(1)
are valid only as a statistically average meaning of
overall cases collected in the first study, they are
insufficient to predict postsurgical survival time for
any individual patient in the group. Namely, in order
topredict survival time for an individual patient, the
patient population should first be divided into some
subgroups sothattheprediction maybeapplicable to
each divisive subgroup.
In the present report, at first, cluster analysis was
performed in the cases entered in the first study,
identical to those subjected to the previous report
(1), and the prediction ofprognosis wasevaluated on
eachcluster. Secondly, the censoredadjustmentwas
addedtothesimpleregression ofsurvival timeonthe
prognostic factors presented in the previous report
(1) in order to predict prognosis. The distinction
between the evaluation of prediction of prognosis
and the prediction of prognosis itself was auto-
matically clarified through the course of our
analyses. Prediction for survival time expressed in
month was given from the regression ofthe time on
each cluster. Characteristics ofpatients were exam-
ined in two clusters, one in which amarked effect of
chemotherapy was observed and the otherwith little
effect of chemotherapy.
Clinical Cases
In the same manner as described in our previous
report, 430 cases were chosen from 509 cases (237
casesreceivingchemotherapy, and270cases used as
controls), which were collected and examined by
Imanaga and his co-workers in W-I cooperative
study group sponsored by the Japan Ministry of
Health and Welfare during 10 years from January
1965 to December 1974. Those who died either dur-
ing operation or from causes apparently other than
cancer were excluded. The remaining 430 patients
were confirmed as stomach cancer by pathological
diagnosis, satisfied the presurgical conditions, were
subjected to curative resection of gastric cancer.
Records of sex, age, and tumor descriptions were
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Stomach Cancer Society, including extent of resec-
tion, location oftumor, post-surgical complications,
tumor size, metastasis to lymph nodes, degree of
serosal invasion, and classification by Borrmann
type. To evaluate the validity of our prediction of
prognosis, the prognosis predicted was compared
with survival to December 1976.
Classification and Identification of
Patients
The frequency distribution of patients varied de-
pendingon the prognostic factors extracted from the
nine factors observed mainly at the time ofsurgery.
Without further divisive classification of patient
population, neither the average trends of survival
time nor the prognostic factor described in our pre-
vious reportcan predict survival time forany patient
with stomach cancer. The divisive subclasses should
be mutually exclusive, while the variability ofobser-
vations is homogeneous within the subclass. Com-
monly, classification of mass of individuals into a
given "natural" group is called "dissection of
mass," which is one of some methods of cluster
analysis. During the course of extraction of prog-
nostic factors in the manner described in our previ-
ous report (1), sex and age were excluded from the
prognostic factors because these are not heavily re-
lated toprognosis. The remainingsevenfactors, i.e.,
extent of resection, location of tumor, postsurgical
complications, tumor size, metastasis to lymph
node, degree ofserosal invasion and classification in
Borrmann type, were used for the cluster analysis.
Here we used the Ward technique in the cluster
analysis. Thus, the patient population was divided
into subclasses according to similarity of patients
measured by Euclidian distances on seven factors
mentioned above.
In the present study, in order to exclude possible
variation due to institutional difference, the patients
were at first divided into three groups such as the
Aichi Cancer Center group, the Cancer Research
Institute Hospital group, and the group of patients
from other institutes. Then, the cluster analysis was
carried outforeach group. Figure 1 shows a dendro-
gram ofclustering given to 137 cases collected from
theAichiCancerCenterHospitalduringthefirstW-I
study. All the cases were divided into 10 clusters
from G1 to G1o, depending on their characteristics
clarified atthetime ofsurgery and the 10clusters are
shownatthebottomofthedendrogram. The average
characteristics of the patients in each cluster are
given in a corresponding radar chart which was
drawn by connecting the points ofaverage values of
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FIGURE 1. Dendrogramofthefactors influencingprognosis: Aichi
Cancer Center Hospital data.
theclusteron seven axes representing seven catego-
ries stated above. The dendrogram shows a se-
quenceofdividingorjoiningofclusters. Theclusters
with similar characteristics were combined step by
step. Forexample, at firstG2 andGlowerecombined
to form G(2, 10) and similarly G(, 5) was formed from
GI andG5, G(4,6), fromG4 andG6, andG(3 9), fromG3
and Gg. Furthermore, G(2, 1o) and G(L 5) were com-
bined to form G(2, 10) (1 5)-
The average survival time was estimated for each
cluster and is given together with the maximum and
the minimum values under the corresponding radar
chart in Figure 1. With clusters ofG4 andG6 charac-
terized by longer survival time, G2 and G,o charac-
terizedby shortersurvival time, andG5andG8which
submitted to subsequent evaluation for the chemo-
therapy, the clinical records for 11 variables are
tabulated inTable 1. Patients contained in clusterG4
are in moderately advanced stage and characterized
as follows: extent ofresection, pylorus; location of
tumor, mostly M; complications, none; size of
tumor, mostly below 5; metastasis to lymph nodes,
mostly none; degree of serosal invasion, mostly s;
Borrmann types, 1 - 2 type. Patients intheG6 cluster
arealsocharacterized as similartoclusterG4, except
that location of tumor was A and that serosal inva-
sionwasessentiallyso. Tumorsinpatients inG6 were
rather less advanced than those in G4. Characteris-
tics of each cluster are outlined in Table 2.
Similarly, 10 clusters were produced from either
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Cluster Borr- Time,
No. No. Patient Sex Age Res. Loc. Compl. Size n s mann months Statusa
G1 1 110 I M 69 Dis.
2 110 15 F 45 Dis.
3 110 41 F 63 Dis.
4 110105 M 49 Dis.
5 110123 M 63 Dis.
6 110143 M 58 Dis.
7 110169 M 53 Dis.
8 110171 F 69 Dis.
9 110187 F 60 Dis.
10 110201 F 59 Dis.
11 120 6 M 71 Dis.
12 120 12 M 55 Dis.
13 120 14 F 40 Dis.
14 120 18 M 73 Dis.
15 120 70 M 43 Dis.
16 120 80 F 66 Dis
17 120 88 F 66 Dis.
18 120100 M 63 Dis.
19 120124 M 63 Dis.
20 120136 M 41 Dis.
21 120170 F 38 Dis.
22 120186 F 55 Dis.
Survival time, months (mean + SD) 50.59 + 46.45
G2 1 110 5 F 47 Tot.
2 110 75 M 64 Tot.
3 110115 M 67 Tot.
4 110139 F 54 Dis.
5 110173 M 55 Tot.
Survival time, months (mean ± SD) 25.60 ± 17.36
G3 1 110 7 M 59 Dis.
2 110 39 M 48 Tot.
3 110 83 M 62 Dis.
4 110 85 F 35 Dis.
5 110137 F 67 Dis.
6 110147 M 53 Dis.
7 110161 M 48 Dis.
8 120 20 F 53 Dis.
9 120 26 M 71 Dis.
10 120 30 M 63 Dis.
11 120 50 M 58 Dis.
12 120 68 M 64 Dis.
13 120 74 M 66 Dis.
14 120120 F 41 Dis.
15 120142 F 64 Dis.
16 120164 F 51 Dis.
17 120218 F 46 Dis.
Survival time, months (mean ± SD) 87.59 ± 46.28
A None 6-9 2-4
A None -5 2-4
A None 6-9 2-4
A None -5 2-4
A None -5 2-4
A None -5 2-4
A None -5 2-4
A None 10- 2-4
A None 6-9 2-4
M None 6-9 2-4
A None 6-9 2-4
A None -5 2-4
A None -5 1
A None 6-9 2-4
A None 6-9 2-4
A None 6-9 2-4
A None 6-9 2-4
A None 6-9 2-4
A None -5 1
A None 6-9 2-4
A None 6-9 2-4
A None 6-9 2-4
A Pre. 10- 2-4
All Pre. 10- 0
All None 6-9 0
A Pre. 6-9 2-4
All None 10- 2-4
A None 6-9 0
A None 10- 0
A None 6-9 0
A None 6-9 0
A None 6-9 0
A None -5 0
A None 6-9 0
A None 6-9 1
A None 6-9 0
A None 6-9 0
A None 6-9 0
A None 6-9 0
A None -5 0
A None 6-9 0
A None 6-9 1
A None 6-9 0
M None 10- 0
2-3 1-2 12 D
2-3 1-2 12 D
2-3 3 19 D
1 1-2 117 S
2-3 3 11 D
1 1-2 118 S
1 3 11 D
1 4-5 7 D
1 1-2 17 D
2-3 1-2 53 D
2-3 3 17 D
0 4-5 4 D
2-3 3 74 D
2-3 1-2 129 S
0 3 118 S
2-3 1-2 11 D
0 4-5 53 D
1 3 115 S
2-3 3 35 D
1 3 34 D
2-3 3 26 D
1 1-2 120 S
2-3 1-2 43 D
2-3 4-5 38 D
2-3 3 33 D
2-3 3 8 D
1 4-5 6 D
0 3 130 S
0 0 127 S
0 3 117 S
0 3 116 S
0 1-2 53 D
1 3 16 D
1 3 123 S
0 3 20 D
0 1-2 107 D
2-3 3 49 D
0 0 117 S
0 3 124 S
1 3 9 D
1 3 113 D
0 1-2 25 D
0 0 120 S
0 0 123 S
G4 1 110 11
2 110 17
3 110 45
4 110 47
5 110 63
6 110 67
7 110 81
8 110 95
9 110 99
10 110107
11 110111
12 110113
13 110117
F 32 Dis.
M 54 Dis.
F 60 Dis.
M 52 Dis.
M 57 Dis.
M 44 Dis.
M 58 Pro.
F 47 Dis.
M 51 Dis.
M 64 Dis.
M 60 Dis.
F 48 Dis.
M 49 Dis.
M None -5
M None -5
A None -5
M None -5
A None -5
M None -5
C None 6-9
M None -5
M None -5
M None 6-9
M None -5
M None -5
M None 6-9
0 0 0 129 S
2-4 0 1-2 130 S
0 2-3 1-2 79 D
0 0 0 125 S
0 2-3 1-2 115 S
0 2-3 1-2 122 S
I 0 1-2 81 D
0 0 1-2 55 D
I 1 1-2 117 S
0 1 1-2 61 D
0 1 1-2 119 S
0 1 1-2 124 S
0 0 3 118 S
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Cluster Borr- Time,
No. No. Patient Sex Age Res. Loc. Compl. Size n s mann months Statusa
G4 14 110129 M 44 Dis.
15 110133 M 64 Dis.
16 110149 M 53 Dis.
17 110179 M 53 Dis.
18 110189 M 64 Dis.
19 120 2 M 64 Dis.
20 120 34 M 55 Dis.
21 120 36 M 55 Dis.
22 120 54 M 53 Dis.
23 120 90 M 54 Dis.
24 120 98 F 52 Dis.
25 120132 M 51 Dis.
26 120134 M 42 Dis.
Survival time, months (mean ± SD) 101.35 ± 33.92
G5 1 110 49 M 41 Dis.
2 110 93 F 50 Dis.
3 110 97 F 68 Dis.
4 110185 M 60 Dis.
5 120 24 M 75 Dis.
6 120 38 M 52 Dis.
7 120 78 F 64 Dis.
8 120 86 M 35 Dis.
9 120112 M 60 Dis.
10 120138 M 62 Dis.
11 120168 M 54 Dis.
12 120244 M 48 Dis.
Survival time, months (mean ± SD) 54.00 ± 43.01
G6 1 110 21 M 35 Dis.
2 110 27 F 48 Dis.
3 110 31 F 57 Dis.
4 110 33 M 33 Dis.
5 110 37 M 46 Dis.
6 110 59 M 50 Dis.
7 110 61 M 51 Dis.
8 11091 M 64 Dis.
9 110135 M 32 Dis.
10 110175 M 49 Dis.
11 110207 M 44 Dis.
12 110209 M 46 Dis.
13 120 16 F 62 Dis.
14 120 28 F 48 Dis.
15 120 40 M 67 Dis.
16 120 44 M 30 Dis.
17 120 58 M 54 Dis.
18 120 66 M 55 Dis.
19 120 72 M 54 Dis.
20 120 82 M 65 Dis.
21 120 84 M 61 Dis.
22 120 92 M 58 Dis.
23 120 94 F 50 Dis.
24 120114 M 55 Dis.
25 120122 M 32 Dis.
26 120128 M 54 Dis.
27 120130 M 57 Dis.
28 120166 M 66 Dis.
29 120184 M 55 Dis.
30 120220 M 71 Dis.
31 120224 M 38 Dis.
Survival time, months (mean ± SD) 109.16 ± 31.24
M None -5
M None -5
M None -5
A None -5
M None -5
M None -5
C None -5
M None -5
M None -5
C None 6-9
M None -5
M None -5
M None -5
A None 10-
A None 6-9
A None 6-9
M None 6-9
A None 10-
A None 6-9
A None 6-9
All None 10-
A None 10-
A None 6-9
A None 10-
A None 6-9
A None
A None
A None
A None
A None
A None
A None
A None
A None
A None
A None
A None
A None
A None
A None
A None
A None
A None
A None
A None
A None
A None
A None
A None
A None
A None
A None
A None
A None
A None
A None
I
0
0
0
2-4
0
0
0
0
0
1 0
1 1-2 29
1 1-2 120
0 0 131
2-3 1-2 119
1 1-2 101
0 1-2 131
0 0 69
0 0 79
0 1-2 122
1 1-2 4
0 0 117
0 0 119
0 0 119
1 2-3 4-5 83
1 2-3 3 18
1 2-3 4-5 119
1 2-3 4-5 68
0 2-3 1-2 43
1 2-3 1-2 12
1 2-3 1-2 125
0 1 1-2 3
0 2-3 4-5 28
0 2-3 1-2 51
1 2-3 3 7
0 2-3 1-2 91
-5 2-4 0 0 132
-5 2-4 0 0 130
-5 0 0 0 128
-5 1 0 1-2 128
-5 0 0 0 128
-5 1 0 0 31
-5 0 0 0 127
-5 0 0 0 115
-5 2-4 0 0 122
-5 0 0 1-2 118
-5 0 0 0 93
-5 2-4 0 0 92
-5 1 0 1-2 62
-5 0 0 0 124
-5 0 0 1-2 126
-5 0 0 0 115
-5 0 0 0 116
-5 0 0 0 124
-5 0 0 0 123
-5 0 0 0 123
-5 2-4 0 1-2 126
-5 0 0 0 119
-5 0 0 0 119
-5 0 0 1-2 115
-5 0 0 0 123
-5 0 0 0 121
-5 0 0 1-2 21
-5 0 0 0 119
-5 1 0 0 22
-5 1 1 1-2 121
-5 0 0 0 121
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Cluster Borr- Time,
No. No. Patient Sex Age Res. Loc. Compl. Size n s mann months Statusa
G7 1 110 57 M 67 Pro. C Pre. 6-9 2-4 2-3 3 12 D
2 110101 F 45 Dis. M Pre. 10- 0 2-3 3 118 S
3 120 42 M 32 Pro. M Pre. 6-9 1 0 3 127 S
4 120148 F 43 Pro. C Pre. 10- 0 2-3 3 128 S
5 120246 F 62 Pro. C Pre. 6-9 1 2-3 1-2 18 D
Survival time, months (mean ± SD) 80.60 ± 60.05
G8 1 110 89 M 55 Tot. C Pre. 6-9 2-4 1 3 15 D
2 110141 M 61 Tot. C Pre. -5 2-4 1 1-2 95 S
3 110153 M 40 Tot. C Pre. -5 0 2-3 1-2 125 S
4 110203 F 41 Tot. M Pre. 6-9 1 2-3 3 105 S
5 120 48 M 71 Tot. C Pre. -5 1 2-3 1-2 35 D
6 120 52 F 44 Tot. M Pre. -5 0 1 1-2 119 S
7 120118 F 41 Tot. M Pre. -5 1 2-3 3 23 D
8 120126 M 63 Tot. C Pre. -5 2-4 1 3 7 D
Survival time, months (mean ± SD) 65.50 ± 50.06
Gg 1 110167 M 46 Dis. A Pre. -5 0 1 3 24 D
2 110199 M 53 Dis. C Pre. -5 2-4 0 1-2 109 S
3 120 8 M 33 Dis. M Pre. 6-9 0 0 1-2 131 S
4 120 56 F 61 Dis. C Pre. 6-9 0 0 0 120 S
5 120 62 M 62 Dis. A Pre. -5 0 0 1-2 119 S
6 120 64 F 60 Dis. A Pre. -5 0 0 0 119 S
7 120140 F 52 Tot. A Pre. 6-9 0 0 1-2 23 D
Survival time, months (mean ± SD) 92.14 ± 47.32
G1o 1 110193 F 54 Tot. M None 6-9 1 2-3 3 11 D
2 120 46 M 57 Tot. M None -5 2-4 2-3 3 10 D
3 120108 F 38 Tot. A None 6-9 1 1 1-2 12 D
Survival time, months (mean ± SD) 11.00 ± 1.00
aD = dead; S = survivor.
169 cases from the Cancer Research Institute Hos- indicating that contribution ofprognostic factors to
pital or 124 cases from the other institutions and the survival time was not homogeneous.
radar chart is given for each cluster together with To examine the actual prognosis of individual
average survival time and the maximum-minimum clustersgiven inTable 2, thefive-yearsurvivalorthe
values(Fig. 2). The reification ofthe clusteranalyses five-year mortality was calculated for each cluster
like Table 2 is omitted from the present report for and these values are given in Table 3 and Figure 3.
these two groups. Institutional differences of"anat- The survival ratesgiven inTable 3 wereestimatedby
omy" of the cluster was observed to some extent, making useofthe methodofKaplanand Meier(2)for
Table 2. Reification of individual clusters.
Extent of Postsurgical Degree of
Cluster resection Location complications state Note
G, Distal A None Serious Size = 6-9, n = 2-4
s = 2-3, Borrmann = 3
G2 Total A, All Present Serious
C3 Distal A None Slight Size = 6-9, n = 0, s = 0,
Borrmann = 3
G4 Distal C, M None Slight Size = -5, n = 0
Borrmann = 1-2, Male
G5 Distal A None Serious Slight n, serious s
G6 Distal A None Slight Size = -5, n:O, s:O
Borrmann = 0, 1-2, Male
G7 ~~Proximal C, M Present Moderate
G8 Total C, M Present Moderate
Gg Distal C, M, A Present Slight
G1,o Total M None Serious n = 0, s = 0, Borrmann = 0, 1-2
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Average
Maximum
Minimum
Size
Average
Maximum
Minimum
G I GIO G5 G6 G7 G4 G2 G3 G8 G9
38 3 13 9 8 1 1 35 20 19 12
89.2 114.3 62.7 90.0 62.3 41.6 106.9 58.2 92.2 48.0
133 126 131 133 131 125 133 132 133 126
4 103 4 6 6 6 5 8 8 1
GI G6 GIO G7 G9 G5 G3 G4 G2 GB
29
84.6
138
10
12 2 10 4
112.2 4.5 63.4 33.0
132 6 132 104
41 3 5 6
17
43.1
131
9
13
60.4
135
8
12
44.5
126
4
10
60.5
136
3
15
118.3
133
14
FIGURE 2. Radarchart ofeach cluster on seven factors; cases from Cancer Research Institute Hospital
(upper) and other institutes (lower).
these clusters. [Gehan (3) suggested that ingeneral a
popular life table method is not applicable for esti-
mation of either observed survival rate or relative
survival rate ofa group when the population size is
less than50.] With respectto clustersG5 andG8, the
survival rate orthe death rate ofthe group receiving
chemotherapy wasdifferentfrom that ofthe control
group. Itisinterestingto note thatfive-year survival
orfive-year mortality in the chemotherapy group is
different from that in controls among those with
stomach canceradvanced slightly morethan moder-
ate degree. There was no significant difference in
five-year survival or five-year mortality between
groups receiving chemotherapy and control groups
in clusters G4 and G6 which were characterized by
longsurvival time aftermedication and inclusterG10
which characterized by death shortly after surgery.
Thisevidence supportsourpreviousreport(1)onthe
effect ofpostoperative chemotherapy.
Table3.Five-yearsurvival rateforindividualclustersbymethodof
Kaplan and Meler: Cases at Aichi Cancer Center.
5-yr survival rate
Treated Control
Cluster group group Total
G, 0.200 0.417 0.378
G2 0.000 0.000
G3 0.714 0.600 0.647
G4 0.889 0.875 0.885
G5 0.750 0.250 0.417
G6 0.917 0.900 0.906
G7 0.500 0.667 0.600
G8 0.750 0.250 0.500
Gg 0.500 0.800 0.714
G1o 0.000 0.000 0.000
Prediction of Prognosis
In the previous report (1), one prognostic factor
was extracted from nine factors at the time of
surgery, andtheeffect ofthe prognostic factor onthe
postoperative survival time was discussed. The av-
erage survival time was 67.2 months in the control
group in a patient population collected by the first
W-I study with observation period till December
1974, and this value was compared to the prognostic
Failure
rate
(%
1001
treated group
x.......-x :control group
- : total
FIGURE 3. Failure rate less than five years for each cluster.
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the censored adjustment
Y=4.55x +91.19
a. 100.0-
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Ordinary regression line
Y=2.65x+67.19
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FIGURuE 4. Comparison of the regression with the censored ad-
justment and the ordinary regression for control group.
factor to determine its value in prognosis. A least-
square regression line of postsurgical survival time
onthe prognostic factorwasestimated anddrawn on
the scatter diagram as if the line separates the
patients morbid within a 67.2 month period after
surgery from the patients surviving more than the
same period. The regression line was advantageous
from point ofview ofevaluating prediction ofsurvi-
val time based on the prognostic factor. However, it
is inevitable in survival time studies like this that the
pointoffollow-uptime aftersurgery varieseachtime
and that a portion of the cases under observation
may be assigned to censored survival time due to
incomplete observation whenever the survey was
conducted. Use ofthe time period between surgery
and survey time in the place of survival time may
cause underestimation of survival time. Therefore
the least-squares regression analysis requires some
adjustment for incomplete observation to predict
survival time.
Based on the data for cases collected by the first
W-I study, a regression line with censored adjust-
ment is given in Figure 4 together with an ordinary
regression line as reported in the previous report (1).
The ellipses in the figure are those of 95% critical
regions for two groups ofshort-time death and long-
time survival, which were classified by the above-
stated period of 67.2 months for the survival time
after surgery. The ordinary regression line is drawn
to divide the two groups, while the regression line
withthe censored adjustment passes inthe middle of
thelong-term survivors, indicatingthat survival time
may be predicted by making use of the regression
line with the censored adjustment. In order to com-
pare the ordinary regression analysis and the regres-
sion analysis with the censored adjustment, survival
time was predicted forthose alive in December 1974
and the values were compared with survival time
observed by survey carried out in December 1976.
The results are shown in Figure 5. The evaluation of
the predictions was expressed by deviation of the
predicted survival time from observed value. The
values of survival time predicted by the ordinary
regression analysis deviated from the observed val-
uesexclusively towards the negative side, indicating
underestimation, while those predicted by regres-
sion analysis with the censored adjustment deviate
to both sides, reducing deviation as a whole. Thus,
theregression analysis withthe censored adjustment
compares favorably with the ordinary regression
analysis as far as survival time predicted for those
alive in December 1974 is concerned.
The average survival time was estimated by the
regression analysis with the censored adjustment for
control groups of each cluster of the Aichi Cancer
Center group. The results are given in Table 4. The
results indicate the evaluation of the interpolation
regression analysis in each cluster. The censored
adjustmentofregression improved the predictability
of survival time in such clusters characterized by a
long survival time (G6, G9), while the results are not
very satisfactory for shorter survivors (G5, G6). The
censored adjustment many be effective forthe survi-
val time study based on the observation for alimited
period.
40
Ordinary
FIGURE 5. Comparison of the regression with the censored ad-
justment and the ordinary regression on the deviations be-
tween the predicted values and the actual censored observa-
tions.
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SomeComments on DataAnalysis
Similar to the previous report (1), based on the
data for cases collected during the first W-I study
under aproject sponsored by the Ministry ofHealth
andWelfare, divisive grouping ofpatients according
to their characteristics and prediction oftheir prog-
nosis was examined. The major subject ofa survival
time study is in general the survival time ofpatients,
and problems which we should consider are how to
understand and to characterize the survival time. In
thepresent report, various analyses were conducted
inorder to examine three subjects mentioned in the
introduction. Survival time distribution should be
discussedpriortotheanalyses. Weibulldistribution,
gamma distribution, or log-normal distribution may
theoretically fit the survival time distribution, al-
though the present survival time data have shown
strong conformity with none of these distributions.
Therefore survival time was used in the regression
analysis without any data transformation. The ad-
justmentforthe data to one ofthe standard distribu-
tions remained to be studied. Although relative sur-
vival rate and observed survival rate, both ofwhich
are presented in a form of life table, are commonly
used as one of measurements to estimate prognosis
ofstomachcancer, they arenonparametric estimates
exclusively applicable for a group of large sample
size. For a group of small sample size, survival rate
estimated by the method ofKaplan and Meier(2), as
described in this report, seems to be fit well for a
nonparametric estimate.
Cluster analysis, as described in this report, is an
expedient means in which patient population is di-
vided into subgroups as naturally as possible based
on the similarity of a given characteristic. Con-
sequently reproducibility of the results depends
solelyonthe method ofdividing intoclusters and the
scale ofsimilarity. The presentclusteranalysis, i.e.,
Ward technique, is merely an attempt to utilize the
general tendency reported in the previous report (1)
to predict prognosis for individual patients. Some
informations obtained in the process are ofpractical
importance. For example, the anatomy of each
cluster listed in Table 2 and prognosis records given
in Figure 5 may serve for prediction of individual
prognosis on the characteristics of the patient.
Itseemsnecessarytodevelopamixedalgorithmin
Table 4. Evaluation by interpolation for regression with censored
adjustment: control cases of Aichi Cancer Center.
Mean Prediction Prediction
Cluster (observation) (ordinary) (censored)
G1 61.33 63.11 84.17
G2_
G3 80.70 77.15 108.26
G4 95.00 87.27 125.62
G5 45.00 61.04 80.61
G6 107.36 93.21 135.81
G7 91.00 32.11 30.98
G8 46.00 41.85 46.69
G9 102.40 70.37 96.62
GIO 11.00 52.66 66.24
October 1979 illwhich the patient population isfirstdivided into sub-
groups by nonhierachical clustering, followed by
hierarchical clustering. Censored adjustment of re-
gression with incomplete observation is also neces-
sary as far as prediction is concerned. The censored
adjustment is applicable notonlyto single regression
as stated in this report, but also to multiple regres-
sion. For example, in order to make categorical re-
gression analysis as described in the previous report
[4]toapatientpopulationincludingthose stillalive at
the point of survey, the censored adjustment was
applied as shown in Figure 6. The weights assigned
toindividual characteristics appeartobe sufficiently
reasonable except for one assigned to postsurgery
complication.
Conclusion
Prediction ofprognosis and classification ofa pa-
tient population into homogeneous subgroups were
examined in the present report as a part ofstudy on
prognostic factor in patients receiving surgery for
stomach cancer. Special attention was paid to in-
complete observations specific to the survival time
study. It was proved that censored adjustment of
regression is necessary in predictionofprognosis. In
addition, clusteranalysis was proved to be useful for
prediction ofpatient prognosis by the aid ofa statis-
tical rule which primarily was reified in the practi-
cal clinical field.
The authors are indebted first and foremost to Dr. Hajime
Imanaga (Aichi Cancer Center Hospital) whogave them valuable
suggestions andguidance, and also ProfessorTakeaki Nagai (Oita
University) whogave themhelpful commentsanddiscussionsand
supported them in many ways.
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